by Elena Iemma | May 16, 2023 | Featured, News
EpiVax is celebrating 25 years of innovative immunoinformatics tool development. The company’s mission is to improve the safety and efficacy of vaccines and protein therapeutics, while working to improve human health everywhere. 1998 EpiVax Founded by Dr. Annie De...
by Corey Iacono | Mar 13, 2023 | Featured, Thinking Out Loud -Blog
Silicon Valley Eats its Own Accelerated by twitter alerts advising venture investors to pull their cash, the Silicon Valley Bank in Santa Clara collapsed and was taken over by the FDIC on Friday. Tech Brahmans on the “All In” Podcast (the podcast I love to...
by Annie De Groot | Jan 17, 2023 | Featured, Thinking Out Loud -Blog
At GREAT risk of dating myself, nearly 20 years ago, I flew to a meeting in an obscure hotel in Ames, Iowa to give a talk on in silico methods for vaccine design (link is to the latest publication on the tools). On the way to my room, I shared an elevator with...
by Sameer Laul | Jan 10, 2023 | News
PROVIDENCE, RI, January 10, 2023 /PRNewswire/ — EpiVax, Inc. (“EpiVax”) and Zoetis, are pleased to announce an exclusive collaboration to develop CircoMatch™, a unique bioinformatics tool that predicts the coverage of Porcine Circovirus Type 2 (PCV2) vaccines...
by Sameer Laul | Jan 9, 2023 | News
EpiVax, Inc. is excited to announce that its subsidiary, EpiVax Therapeutics, has signed an exclusive collaboration agreement with GreenLight Biosciences to advance the development of personalized cancer vaccines. The effort will combine GreenLight’s mRNA...